£136.54

It has never been this cheap. We have no record of a lower price.

£137 today · cheaper than every other day in the last 3 months

Humana Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£136.54 £129.71 £132.44 £135.17 £137.91 £140.64 £143.37 25 July 2026 09 August 2026 24 August 2026 08 September 2026 24 September 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 1 price levels

Days at Price
62 days 0 16 31 47 62 £137 Days at Price

Price Analysis

Most common price: £137 (62 days, 100.0%)

Price range: £137 - £137

Price levels: 1 different prices over 62 days

Description

Many of the trace amines-more correctly called biogenic amines have been known for decades, but because of their tiny concentra tions (0. 01-100 ng/g) in brain, it was only after the development of sophisticated analytical techniques (such as mass spectrometry) that they could be identified and quantitated in nervous tissue. There are now more than 20 of them and most are related to the catecholamines and 5-hydroxytryptamine both structurally and metabolically. Their pharmacological and physiological properties make them prime candidates for a transmitter or neuromodulator role and many of them elicit profound behavioral syndromes after injection--one of them, phenylethylamine, has even been referred to as nature's amphetamine. In the clinical sphere several have been shown to be involved in: Parkinsonism, schizophrenia, depression, agoraphobia, aggression, hyperkinesis, migraine, hypertensive crises, hypertyrosinemia, he patic encephalopathy, epilepsy, and cystic fibrosis. Thus the research reported here on these intriguing "new" substances will be of great interest to psychiatrists, neurologists, biochemists, pharmacologists, physiologists, psychologists, behaviorists and indeed to all those working in the neurosciences and related fields today. ACKNOWLEDGMENTS This book is based on the proceedings of Trace Amines and the Neurosciences, a meeting held at the University of Alberta, Edmonton, July 19-21, 1983. This meeting was organized as a Satellite Meeting of the Ninth Meeting of the International Society for Neurochemistry, held in Vancouver, July 10-15, 1983. International organizers of the satellite meeting were Drs. A. A. Boulton (Saskatoon), W. G. Dewhurst (Edmonton), G. B. Baker (Edmonton), and M. Sandler (London).

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Release Date
16 April 2013
Listed Since
07 November 2013

Barcode

No barcode data available

Similar Products You Might Like

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
97% match

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Humana

£165.06 03 Sep 2026
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
97% match

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Humana

£141.86 02 Oct 2026
Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
96% match

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

Elsevier

£82.62 26 Sep 2026
Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment
96% match

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

Springer

£114.88 02 Oct 2026
Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward
96% match

Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward

£85.65 17 Sep 2026
Springer Staging Neuropsychiatric Disorders Medical Book
96% match

Springer Staging Neuropsychiatric Disorders Medical Book

Springer

£107.47 03 Oct 2026
Transmitter Molecules in the Brain: Part I: Biochemistry of Transmitter Molecules Part II: Function and Dysfunction: 2 (Basic and Clinical Aspects of Neuroscience, 2)
95% match

Transmitter Molecules in the Brain: Part I: Biochemistry of Transmitter Molecules Part II: Function and Dysfunction: 2 (Basic and Clinical Aspects of Neuroscience, 2)

Springer

£43.23 23 Sep 2026
Serotonin: From Cell Biology to Pharmacology and Therapeutics
95% match

Serotonin: From Cell Biology to Pharmacology and Therapeutics

Springer

£236.59 12 Sep 2026
5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)
95% match

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Humana

£141.67 24 Sep 2026
Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)
95% match

Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)

Elsevier

£129.00 01 Oct 2026
Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)
95% match

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Springer

£128.31 27 Aug 2026
Neuropathology of Drug Addictions and Substance Misuse: Volume 2: Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects
95% match

Neuropathology of Drug Addictions and Substance Misuse: Volume 2: Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects

Elsevier

£141.90 26 Aug 2026
Dopamine Receptor Technologies: 96 (Neuromethods, 96)
95% match

Dopamine Receptor Technologies: 96 (Neuromethods, 96)

Humana

£79.93 01 Oct 2026
Neurotoxin Modeling of Brain Disorders ― Life-long Outcomes in Behavioral Teratology: 29 (Current Topics in Behavioral Neurosciences, 29)
95% match

Neurotoxin Modeling of Brain Disorders ― Life-long Outcomes in Behavioral Teratology: 29 (Current Topics in Behavioral Neurosciences, 29)

Springer

£109.08 28 Aug 2026
Academic Press Handbook of Behavioral Neurobiology of Serotonin
95% match

Academic Press Handbook of Behavioral Neurobiology of Serotonin

Elsevier

£135.00 01 Oct 2026
Advances in Neuropharmacology: Drugs and Therapeutics
95% match

Advances in Neuropharmacology: Drugs and Therapeutics

CRC Press

£77.00 26 Sep 2026
Receptor Localization: Laboratory Methods and Procedures: 18 (Receptor Biochemistry and Methodology)
95% match

Receptor Localization: Laboratory Methods and Procedures: 18 (Receptor Biochemistry and Methodology)

Wiley

£198.38 26 Sep 2026
Receptor-Receptor Interactions in the Central Nervous System: 140 (Neuromethods, 140)
95% match

Receptor-Receptor Interactions in the Central Nervous System: 140 (Neuromethods, 140)

Humana

£80.65 11 Sep 2026
Neurochemistry of Abused Drugs - CRC Press Medical Reference
95% match

Neurochemistry of Abused Drugs - CRC Press Medical Reference

CRC Press

£146.63 02 Oct 2026
Muscarinic Receptor: From Structure to Animal Models: 107 (Neuromethods, 107)
95% match

Muscarinic Receptor: From Structure to Animal Models: 107 (Neuromethods, 107)

Humana

£84.46 24 Sep 2026
Designer Receptors Exclusively Activated by Designer Drugs: 108 (Neuromethods, 108)
95% match

Designer Receptors Exclusively Activated by Designer Drugs: 108 (Neuromethods, 108)

Humana

£54.48 18 Sep 2026
Oxidative Stress and Dietary Antioxidants in Neurological Diseases
95% match

Oxidative Stress and Dietary Antioxidants in Neurological Diseases

Elsevier

£137.39 24 Sep 2026
Neurobiology of Amino Acids, Peptides and Trophic Factors: 8 (Topics in Neurosurgery, 8)
95% match

Neurobiology of Amino Acids, Peptides and Trophic Factors: 8 (Topics in Neurosurgery, 8)

Springer

£108.01 30 Sep 2026
Cognition and Mood Interactions
95% match

Cognition and Mood Interactions

£75.98 25 Sep 2026